Chemed (NYSE:CHE) Releases FY 2026 Earnings Guidance

Chemed (NYSE:CHE) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 23.250-24.250 for the period, compared to the consensus EPS estimate of 23.420. The company issued revenue guidance of -.

Chemed Trading Down 0.4%

CHE stock traded down $1.70 during midday trading on Wednesday, reaching $466.62. 248,918 shares of the company’s stock traded hands, compared to its average volume of 165,709. Chemed has a 52-week low of $408.42 and a 52-week high of $623.60. The stock has a market cap of $6.61 billion, a P/E ratio of 24.68, a PEG ratio of 2.33 and a beta of 0.44. The stock’s 50-day moving average is $446.53 and its 200 day moving average is $444.22.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The company had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, research analysts expect that Chemed will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Monday, February 23rd will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, February 23rd. Chemed’s dividend payout ratio is currently 12.69%.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada dropped their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $555.50.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its holdings in shares of Chemed by 4.4% in the fourth quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after purchasing an additional 21,932 shares during the last quarter. AQR Capital Management LLC boosted its position in Chemed by 89.2% in the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after buying an additional 153,469 shares during the period. Epoch Investment Partners Inc. grew its stake in Chemed by 29.4% in the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock worth $137,579,000 after acquiring an additional 69,878 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Chemed by 3.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 247,469 shares of the company’s stock worth $105,885,000 after acquiring an additional 7,289 shares during the period. Finally, Northern Trust Corp increased its position in shares of Chemed by 6.7% during the third quarter. Northern Trust Corp now owns 215,196 shares of the company’s stock worth $96,352,000 after acquiring an additional 13,489 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.